Detail
LncRNA Name | MALAT1 |
Synonyms | MALAT1, HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, PRO1073, MALAT-1, mascRNA |
Region | GRCh38_11:65497688-65506516 Sequence |
Ensembl | ENSG00000251562 |
RefSeq | NR_002819 |
Circulating | ✔ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | thyroid cancer |
ICD-0-3 | C73.9 |
Methods | qPCR, Western blot |
Sample | thyroid cancer tissues, cell lines (SW1736, KAT18, FTC133, HGC-27) |
Expression Pattern | up-regulated |
Function Description | The higher levels of MALAT-1 and FGF2 were observed in thyroid cancer tissues and in thyroid cancer cells compared to that in the control.in the presence of si-MALAT1, the levels of TNF-a and IL-12 were significantly up-regulated whereas IL-10 was down-regulated in the CM from TAMs. |
Pubmed ID | 28543663 |
Year | 2017 |
Title | LncRNA-MALAT1 Promotes Angiogenesis of Thyroid Cancer by Modulating Tumor-Associated Macrophage FGF2 Protein Secretion.down-regulation of MALAT1 in TAMs reduced proliferation, migration, and invasion of FTC133 cells and inhibited angiogenesis.overexpression of FGF2 blocked the effects of MALAT1 siRNAs on cell migration, invasion, and angiogenesis.MALAT1-mediated FGF2 protein secretion from TAMs inhibits inflammatory cytokines release, promotes proliferation,migration, and invasion of FTC133 cells and induces vasculature formation. |
External Links |
Links for MALAT1 | GenBank HGNC lncrnadb Noncode |
Links for thyroid cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.